SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and life-threatening. Virus-neutralizing monoclonal antibodies are predicted to reduce viral load, ameliorate symptoms, and prevent hos...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:N Engl J Med
Glavni autori: Chen, Peter, Nirula, Ajay, Heller, Barry, Gottlieb, Robert L., Boscia, Joseph, Morris, Jason, Huhn, Gregory, Cardona, Jose, Mocherla, Bharat, Stosor, Valentina, Shawa, Imad, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Shen, Lei, Durante, Michael, Oakley, Gerard, Schade, Andrew E., Sabo, Janelle, Patel, Dipak R., Klekotka, Paul, Skovronsky, Daniel M.
Format: Artigo
Jezik:Inglês
Izdano: Massachusetts Medical Society 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646625/
https://ncbi.nlm.nih.gov/pubmed/33113295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2029849
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items